Latest Headlines

  1. datma Joins GOAL Consortium As A Key Industry Supporter, Advancing Innovation In Academic Genomics And Precision Medicine 11/18/2024

    datma, a leading provider of federated Real-World Data platform and related analytical tools, today announced its role as a GOAL Industry Member Supporter for the Genomics Organization for Academic Laboratories (GOAL), a leading academic consortium dedicated to advancing genomic testing and fostering collaborative innovation among academic and non-profit laboratories.

  2. NVIDIA Opens BioNeMo To Scale Digital Biology For Global Biopharma And Scientific Industry 11/18/2024

    NVIDIA today announced that global pharmaceutical and techbio industry leaders, academic pioneers and AI researchers are adopting the open-source NVIDIA BioNeMo Framework to advance drug discovery and accelerate molecule design.

  3. Augurex Life Sciences And Quest Diagnostics Collaborate To Improve Rheumatoid Arthritis Diagnosis And Management 11/15/2024

    Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that it has formed a nonexclusive agreement with Quest Diagnostics, a leading provider of diagnostic information services, under which Quest will validate and offer a lab-developed test based on the Augurex 14-3-3η (eta) biomarker in the United States.

  4. Avantor® Opens New Bridgewater Innovation Center Focused On Solving Life Science's Biggest Challenges 11/14/2024

    Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the opening of its new flagship Bridgewater Innovation Center.

  5. ImageBiopsy Lab Launches IB Lab FROG: AI-Powered Foot Measurements For Orthopedic Insights 11/13/2024

    ImageBiopsy Lab, a leading provider of AI-powered musculoskeletal imaging solutions, has launched IB Lab FROG. This AI module, CE-cleared under the European Medical Device Regulation (MDR) standards, offers a comprehensive suite of automated measurements on X-rays, designed for radiological and orthopedic foot assessments.

  6. Augurex And New Day Diagnostics Announce Launch Of Anti-14-3-3eta Multiplex Analyte Specific Reagents; Enabling A First-In-Class Diagnostic Test For Axial Spondyloarthritis 11/13/2024

    Augurex Life Sciences Corp. (“Augurex”) today announced the launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents (ASRs), supporting the development of a first-in-class diagnostic test that assists clinicians in the diagnosis of axial spondyloarthritis (axSpA).

  7. Reverb Therapeutics To Collaborate With Royalmount Laboratories On Development Of Advanced Bispecific Antibodies 11/13/2024

    Reverb Therapeutics, a leader harnessing the body’s immune system and cytokine signaling to treat life-threatening diseases, announced it has launched a collaboration with Royalmount Laboratories, based in Montreal, as Reverb works towards lead selection and pre-IND enabling work on its first drug candidate.

  8. Frontage Laboratories And Medicover Integrated Clinical Services Announce Strategic Collaboration To Expand Global Genomic Testing Services 11/12/2024

    Frontage Laboratories, Inc., a global CRO, and Medicover Integrated Clinical Services (MICS), part of Medicover, an international healthcare and diagnostic services company, today announced that the two companies have entered a strategic collaboration for their genomic services.

  9. Dr. Vince Clinical Research Builds Clinical Laboratory Division 11/12/2024

    Dr. Vince Clinical Research (DVCR) is pleased to announce the addition of a cutting-edge clinical laboratory within the main building of its research campus. This new laboratory will significantly enhance the capabilities of its clinical pharmacology unit by enabling in-house safety laboratory testing and streamlining operations.

  10. Everest Biolabs - Elevating Exosome Research With New Tools To Accelerate The Development Of Clinical Applications 11/11/2024

    Everest Biolabs, the life sciences company dedicated to equipping scientists with essential tools for their extracellular vesicle (EV) and exosome research, came out of stealth today with the release of innovative isolation and analytical tools for EV and exosome biomarker research at the 2024 American Association of Extracellular Vesicles (AAEV2024) annual meeting in Houston, Texas.